Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 4 3Phase 2/3 1

Status

Terminated 1Suspended 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Conditions

Head and Neck Neoplasms 3Colonic Neoplasms 3Chronic Pain 3Cancer Pain 3Supratentorial Neoplasms 2Pain, Postoperative 2Pain 2Neoplastic Cells, Circulating 2Neoplasms 2Colorectal Neoplasms 2Agnosia 2Substance Withdrawal Syndrome 1Stomach Neoplasms 1Rectal Neoplasms 1Neoplasm, Residual 1Nasopharyngeal Carcinoma 1Nalbuphine Allergy 1Ileus 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Breakthrough Pain 1Brain Neoplasms 1Age Problem 1Abdominal Cancer 1

Interventions

Morphine 3Fentanyl 2morphine, naltrexone combination 1Oxycodone 1Naltrexone 1Methadone 1Dexmedetomidine 1Buprenorphine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Chronic Pain × Morphine × Clear all
NCT02289261 2018-06-19

A Comparison of Morphine and Morphine Plus Dexmedetomidine in Chronic Cancer Pain

Cukurova University

Phase 4 Completed
40 enrolled

Chronic Pain

NCT00916890 2014-01-09

Prospective Study About Clinical and Pharmacogenetic Safety of Opioid Use for Chronic Pain

Fondazione IRCCS Policlinico San Matteo di Pavia

Phase 4 Suspended
320 enrolled

Cancer Pain, Chronic Pain

NCT01100437 2012-07-13

Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients

Pfizer

Phase 4 Terminated
14 enrolled 18 charts

Substance Withdrawal Syndrome, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡